Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Theatre Turns Teaching Tool at Fairfield University
  • USA - English


News provided by

Fairfield University

Sep 24, 2013, 19:30 ET

Share this article

Share toX

Share this article

Share toX

Shawn Rafalski Ph.D., associate professor of mathematics, and Steve Sawin, Ph.D., professor of mathematics, rehearse "Way to Heaven" at Fairfield University.
Shawn Rafalski Ph.D., associate professor of mathematics, and Steve Sawin, Ph.D., professor of mathematics, rehearse "Way to Heaven" at Fairfield University.

Fairfield, CT (PRWEB) September 24, 2013 -- The play’s the thing at Fairfield University in Fairfield, CT, where a group of professors, administrators and alumni from diverse disciplines are using theatre to take students out of the classroom to look at what they’re learning through a very different – and decidedly Jesuit – lens.

'This is a way of being able to use theatre in an active engagement with our students,' said Jerelyn Johnson, Ph.D. 'It’s another avenue of inquiry, an innovative way to use theatre as a teaching tool.'

Post this

“Way to Heaven,” a play by award-winning Spanish playwright Juan Mayorga, is loosely based on a visit by the Red Cross to the concentration camp of Theresiandstadt during the Second World War. The Germans created a model village — with a synagogue, school, and playgrounds, in order to hide the true nature of the Final Solution. “Way to Heaven” presents the Commandant of the camp, as he works to create the “play” of the model village, and a handful of Jewish internees who are compelled to act in the play, forced to pretend that they are unaware of the machinery of the holocaust that is all around them. Among the cast are the dean of the University’s Charles F. Dolan School of Business, a professor of philosophy, three professors of mathematics, and the chair of the Department of Modern Languages and Literatures, among other actors. This is the third play the group has produced, continuing the project they started with “Perpetual Peace” (2011) and “Glengarry Glen Ross” (2012).

More than 200 students will be attending the public performances as part of their studies, and the play is on the syllabus of courses in philosophy, history, modern languages and literatures, religious studies, and politics. In effect, the play is an exercise in integrative pedagogy – bringing faculty and students together from a number of disciplines to focus on a milestone event in human history, a learning experience made deeply experiential and tangible through the medium of the theater. Each performance will be followed by a different faculty-led discussion.

None of the actors are theatre professionals – and that’s the point. “This is a way of being able to use theatre in an active engagement with our students,” said Jerelyn Johnson, Ph.D., chair of Modern Languages and Literatures and one of the play's producers. “It’s another avenue of inquiry, an innovative way to use theatre as a teaching tool.”

Priests in the Society of Jesus, the religious order that founded Fairfield University, have been using theatre as an immersive teaching tool for centuries, said director Alistair Highet, the University’s director of advancement and student affairs communications.

“They realized it’s a powerful way to reach people,” Highet said. “For instance, this play is about the Holocaust, a historical event so significant it has the danger of becoming abstract. Through theatre, you’re grounding it in a lived experience. And we wanted a play that addresses the big questions – the big Jesuit questions – about justice and the dignity of the person. It’s an expression of a kind of world-friendly pedagogy.”

Watching professors transform into actors can also has a profound effect on the way their students view their own futures. “In addition to the important questions raised by the play, those of us involved in the production are examples of the lifelong learning the University encourages. We’re not boxed into our own separate areas,” said Johnson, who also acts in the play. “We can all continue to try new things and grow throughout our lives.”

Johnson and her co-producer, philosophy professor Dennis Keenan, Ph.D., said Fairfield welcomes outside-the-box thinking from its professors. “It’s organic,” said Keenan, who plays a key character. “It comes from the bottom up.”

Sponsors for the play include the Humanities Institute of the College of Arts and Sciences, the Dolan School of Business, and the Carl and Dorothy Bennett Center for Judaic Studies, as well as several other academic departments.

“The University has been very supportive,” Johnson said. “At Fairfield, you’re really only limited by your own imagination as to what you can do and the ways you can teach.”

Performances of “Way to Heaven” run Wednesday, September 25 through Saturday, September 28 at 8 p.m. and Sunday, September 29 at 2 p.m. All performances will be held in Fairfield University's Wien Experimental Theater of the Regina A. Quick Center for the Arts. Tickets are $20. For tickets, directions, or more information, visit http://www.quickcenter.com, or call the Box Office at (203) 254-4010.

Meredith Guinness, Fairfield University, (203) 254-4000 2950, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.